News

A total of 46 male and female volunteers ranging from 45 to 80 years of age were included in the randomized, double-blind, placebo-controlled cross-over trial. The company said

The research alliance will focus on discovery, research and development of new drugs for some of the common and debilitating gastrointestinal diseases and disorders such as irritable bowel

The product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a

The five-year distribution deal gives FastFunds exclusive distribution rights in the marijuana market segment in the US. The marijuana market segment includes all 50 states, but only applies

Moventig is the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) to be approved in the European Union (EU). The approval was based on data from the KODIAC

NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation

Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates. Additionally, the parties will collaborate to discover and validate new targets that play

The claims in the patent cover, among other inventions, Acura’s IMPEDE Technology, a unique polymer matrix that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine. This

XGEVA was approved and granted Orphan Drug Designation by the FDA, which is reserved for drugs that are intended for the treatment of rare diseases affecting fewer than